Placing of new shares under general mandate

Summary by 6ix AI

Immunotech Biopharm Ltd has announced a placing of new shares under a general mandate to raise funds for research and development and general working capital. The company plans to issue up to a specified number of new shares at a minimum price, with the proceeds expected to strengthen its financial position. The placing is subject to certain conditions and may not proceed if these are not met. The company has previously conducted equity fundraising activities and outlines the intended use of proceeds from this placing.

Written by 6ix AI from the company’s filing. How 6ix writes summaries